(18)Commission Implementing Regulation (EU) 2023/2592note extended the approval period of lenacil to 15 August 2025 in order to allow the renewal process to be completed before the expiry of the approval period of that active substance. However, given that a decision on the renewal of the approval of lenacil has been taken ahead of that extended expiry date, this Regulation should apply earlier than that date.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.